Login / Signup

Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective.

Ashish SharmaNilesh KumarBaruch D KuppermannFrancesco Maria BandelloAnat Loewenstein
Published in: The British journal of ophthalmology (2019)
This review discusses the biosimilars, their regulation globally and their difference from generics from ophthalmic perspective.
Keyphrases
  • artificial intelligence
  • transcription factor
  • deep learning